Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 21 studies | 21% ± 6% | |
CD16-negative, CD56-bright natural killer cell, human | 8 studies | 26% ± 7% | |
CD16-positive, CD56-dim natural killer cell, human | 7 studies | 26% ± 6% | |
epithelial cell | 6 studies | 23% ± 4% | |
plasmacytoid dendritic cell | 4 studies | 20% ± 4% | |
CD8-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
glutamatergic neuron | 3 studies | 35% ± 14% | |
basal cell | 3 studies | 28% ± 12% | |
astrocyte | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4493.54 | 1445 / 1445 | 100% | 24.44 | 183 / 183 |
uterus | 100% | 5685.94 | 170 / 170 | 100% | 18.47 | 458 / 459 |
ovary | 100% | 7290.58 | 180 / 180 | 100% | 18.17 | 429 / 430 |
thymus | 100% | 6130.78 | 653 / 653 | 100% | 18.38 | 603 / 605 |
brain | 100% | 5019.76 | 2636 / 2642 | 100% | 19.78 | 703 / 705 |
prostate | 100% | 6318.12 | 245 / 245 | 99% | 14.69 | 499 / 502 |
intestine | 100% | 4708.90 | 966 / 966 | 98% | 16.33 | 519 / 527 |
bladder | 100% | 5128.76 | 21 / 21 | 98% | 14.10 | 496 / 504 |
adrenal gland | 100% | 3847.92 | 258 / 258 | 98% | 12.75 | 225 / 230 |
kidney | 100% | 3915.35 | 89 / 89 | 98% | 11.53 | 879 / 901 |
skin | 99% | 4298.25 | 1799 / 1809 | 98% | 13.06 | 463 / 472 |
pancreas | 100% | 2266.70 | 327 / 328 | 98% | 13.60 | 174 / 178 |
stomach | 100% | 3239.48 | 359 / 359 | 97% | 15.88 | 277 / 286 |
lung | 100% | 4459.12 | 576 / 578 | 97% | 13.06 | 1119 / 1155 |
liver | 100% | 2544.65 | 225 / 226 | 96% | 7.94 | 389 / 406 |
breast | 100% | 3452.38 | 459 / 459 | 89% | 8.24 | 992 / 1118 |
eye | 0% | 0 | 0 / 0 | 100% | 25.49 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.16 | 29 / 29 |
muscle | 100% | 7264.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5164.94 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.48 | 1 / 1 |
blood vessel | 100% | 3715.41 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 3867.12 | 857 / 861 | 0% | 0 | 0 / 0 |
adipose | 99% | 3167.31 | 1197 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 2093.27 | 844 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003779 | Molecular function | actin binding |
Gene name | MIB2 |
Protein name | MIB E3 ubiquitin protein ligase 2 RING-type E3 ubiquitin transferase (EC 2.3.2.27) E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1) |
Synonyms | SKD ZZANK1 |
Description | FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors. . |
Accessions | F2Z2L2 J3QLE0 ENST00000518681.6 [Q96AX9-4] ENST00000378708.5 [Q96AX9-6] ENST00000502470.5 ENST00000504599.6 [Q96AX9-1] ENST00000378708 ENST00000486072.1 J3QR95 Q96AX9 ENST00000518681 D6RED3 ENST00000505820 ENST00000378712.5 [Q96AX9-10] H0YAM8 ENST00000489635.5 D6RAZ0 ENST00000510793.5 ENST00000514234.5 D6RDI1 A0A8C8USR6 ENST00000355826.10 [Q96AX9-1] ENST00000503789.5 ENST00000487053.5 A0A8C8N694 ENST00000514363.1 ENST00000505820.7 [Q96AX9-1] ENST00000504599 E9PD12 D6RE96 ENST00000520777.6 [Q96AX9-3] D6RFJ2 D6RHY5 ENST00000520777 ENST00000506488.5 ENST00000483015.1 ENST00000355826 D6R9Q6 |